Latest

neuropharmacology

This shows a woman in a doctor's office.

·May 7, 2024·5 min read

Addiction Medication Offers New Hope for Long COVID Patients

Researchers identified a potential treatment for long COVID by restoring the function of ion channels in immune cells using low-dose Naltrexone. This discovery, detailed in Frontiers in Immunology, mirrors earlier findings with chronic fatigue syndrome (ME/CFS) patients, suggesting a common pathophysiological thread between the two conditions.

This shows a brain, RNA and cancer cells.

Brain Cancer Featured Neurology Neuroscience

·May 1, 2024·8 min read

Novel mRNA Vaccine Shows Promise Against Deadly Brain Cancer

Researchers introduced a new mRNA cancer vaccine that rapidly activates the immune system against glioblastoma, the deadliest form of brain tumor. This new vaccine technology, which mimics the structure of COVID-19 vaccines but incorporates personalized tumor cells and a complex cluster delivery system, has shown promising results in preclinical models and an initial human trial involving four adult patients.

Featured Neurology Neuroscience Psychology

·April 20, 2024·7 min read

Risks of Antipsychotic Use in Dementia Patients

A new study revealed significant risks associated with antipsychotic use in dementia patients, including increased chances of stroke, heart failure, pneumonia, and other serious conditions. The research analyzed data from 173,910 dementia patients in England, tracking those prescribed antipsychotics post-diagnosis against those who were not.

Featured Neurology Neuroscience

·April 18, 2024·6 min read

CBD’s Neuroprotective Properties Explored

Summary: Cannabinol (CBN), a cannabinoid derived from cannabis, offers neuroprotective properties that could treat neurological disorders like Alzheimer’s, Parkinson’s, and...

Featured Neurology Neuroscience

·April 18, 2024·4 min read

Treatment Relieves Chronic Lyme Disease’s Neurological Symptoms

Fibroblast growth factor receptor inhibitors, commonly used in cancer treatment, could effectively reduce neurological symptoms in patients with post-treatment Lyme disease syndrome. The study shows these inhibitors can decrease inflammation and cell death in brain and nerve tissues affected by Lyme disease.

This shows a researcher looking at a computer screen.

Featured Neurology Neuroscience

·April 17, 2024·5 min read

AI Revolutionizes Hunt for Parkinson’s Treatments

Researchers employed AI to fast-track the discovery of treatments for Parkinson's disease. They utilized machine learning techniques to screen millions of compounds and successfully identified five promising candidates that prevent the harmful clumping of alpha-synuclein, a key protein in Parkinson’s pathology.

Featured Neurology Neuroscience

·April 16, 2024·5 min read

HIV Drugs May Reduce Alzheimer’s Risk

Common HIV drugs could reduce the incidence of Alzheimer’s disease (AD). Utilizing anonymized prescription data from over 225,000 individuals, the study found that HIV-positive patients taking reverse transcriptase (RT) inhibitors showed a significantly lower rate of AD compared to the general population.

Featured Neurology Neuroscience

·April 16, 2024·4 min read

Monoclonal Antibody Slows Rapid Motor Decline in Parkinson’s

Prasinezumab, a monoclonal antibody targeting alpha-synuclein aggregation, shows promise in slowing motor deterioration in rapidly progressing Parkinson's disease (PD), according to an exploratory analysis from the phase 2 PASADENA clinical trial. While there are currently no disease-modifying treatments for PD, prasinezumab offers a potential breakthrough by specifically binding to aggregated alpha-synuclein, a key driver of PD pathology.

This shows a pregnant woman looking at pills.

Autism Featured Neuroscience

·April 9, 2024·5 min read

Acetaminophen in Pregnancy Not Linked to Autism, ADHD Risk

A comprehensive study involving over 2.4 million Swedish children has debunked the notion that acetaminophen use during pregnancy increases the risk of autism, ADHD, and intellectual disability in offspring. The research employed a novel sibling comparison method to eliminate confounding familial and environmental factors, revealing no increased risk of neurodevelopmental disorders among siblings exposed to acetaminophen prenatally versus those who were not.

Featured Neurology Neuroscience

·April 4, 2024·7 min read

Fecal Bacteria Transplant May Improve Parkinson’s Symptoms

A new clinical trial revealed fecal microbiota transplantation (FMT) as a potential new treatment for Parkinson’s disease (PD), showing significant improvement in motor symptoms. The study explores the connection between the gut microbiome and Parkinson's, finding that patients with PD often exhibit altered gut bacteria and increased intestinal inflammation.

This shows a doctor looking at brain scans.

Featured Neurology Neuroscience

·April 3, 2024·6 min read

Immunotherapy Shows Promise as Alzheimer’s Treatment

Researchers unveiled a novel approach to combat Alzheimer’s disease by activating microglia, the brain's immune cells, to devour amyloid beta plaques, a hallmark of the condition. This study highlights the potential of using immunotherapy to not only tackle Alzheimer’s but also other neurodegenerative diseases characterized by harmful protein accumulations.

Featured Neuroscience Psychology

·March 29, 2024·5 min read

Compound May Curb Alcohol Dependence

The compound LY2444296, which blocks the kappa opioid receptor, significantly reduces alcohol consumption in animal models of alcohol dependence. This study suggests LY2444296 could be a breakthrough in treating alcohol use disorder (AUD) by targeting the brain's KOP system, implicated in addiction and withdrawal symptoms.

1 … 16 17 18 19 20 … 85

neuropharmacology

Addiction Medication Offers New Hope for Long COVID Patients

Novel mRNA Vaccine Shows Promise Against Deadly Brain Cancer

Risks of Antipsychotic Use in Dementia Patients

CBD’s Neuroprotective Properties Explored

Treatment Relieves Chronic Lyme Disease’s Neurological Symptoms

AI Revolutionizes Hunt for Parkinson’s Treatments

HIV Drugs May Reduce Alzheimer’s Risk

Monoclonal Antibody Slows Rapid Motor Decline in Parkinson’s

Acetaminophen in Pregnancy Not Linked to Autism, ADHD Risk

Fecal Bacteria Transplant May Improve Parkinson’s Symptoms

Immunotherapy Shows Promise as Alzheimer’s Treatment

Compound May Curb Alcohol Dependence

Looksmaxxing Trend Poses Health Risks for Young Men

How “Pink Noise” in Conversation Makes Chats Enjoyable

Can Obesity Drugs Protect the Brain?

SuperAger AI Connectome Predicts Alzheimer’s Years Early

Subscribe